PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Fetal Weight D020567 12 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Urticaria D014581 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sarcoidosis D012507 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Georgitis JW et al. Nasal inflammatory mediator release in ragweed allergic rhinitis: correlation with cellular influx into nasal secretions. 1991 Int. Arch. Allergy Appl. Immunol. pmid:1666629
Takayanagi I et al. Effects of aging on alpha 2-adrenoceptor mechanisms in isolated guinea-pig tracheal preparations. 1991 Eur. J. Pharmacol. pmid:1674919
Goerg KJ et al. Antisecretory effect of prostaglandin D2 in rat colon in vitro: action sites. 1991 Am. J. Physiol. pmid:1676243
Fox CC et al. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. 1991 Dig. Dis. Sci. pmid:1703070
Massey WA et al. Profile of prostanoid release following antigen challenge in vivo in the skin of man. 1991 Br. J. Dermatol. pmid:1760357
Shikada K et al. NIP-121 and cromakalim, potassium channel openers, preferentially suppress prostanoid-induced contraction of the guinea-pig isolated trachea. 1991 Eur. J. Pharmacol. pmid:1814761
Gaetani P et al. Effect of high-dose methylprednisolone and U74006F on eicosanoid synthesis after subarachnoid hemorrhage in rats. 1991 Stroke pmid:1900645
Weiler H et al. Studies on the effects of aminopterin and methotrexate on the release of prostaglandin PGE2, PGD2, and PGI2 from small intestine in the rat in vivo. 1991 Clin. Chim. Acta pmid:1769112
Watanabe T et al. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s. 1991 Blood pmid:1718495
Minc-Golomb D et al. Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice. 1991 EMBO J. pmid:1829676
Vesin MF et al. Preferential synthesis of prostaglandin D2 by neurons and prostaglandin E2 by fibroblasts and nonneuronal cells in chick dorsal root ganglia. 1991 J. Neurochem. pmid:2051162
Ramis I et al. In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions. 1991 Prostaglandins pmid:1662405
Fukushima M [Prostaglandins and cell proliferation]. 1991 Tanpakushitsu Kakusan Koso pmid:2024021
White MV et al. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE. 1991 J. Immunol. pmid:1712816
Walmrath D et al. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. 1991 J. Appl. Physiol. pmid:1723406
Vesin MF and Droz B Biosynthesis of prostaglandins D2 and E2 in chick dorsal root ganglion during development. 1991 J. Neurochem. pmid:1904909
Misawa M and Kanai Y Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs. 1991 Arzneimittelforschung pmid:1725697
Abman SH and Accurso FJ Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions. 1991 Am. J. Physiol. pmid:1847014
Sladek K et al. Formation of PGD2 after allergen inhalation in atopic asthmatics. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1847781
King LS et al. Pulmonary vascular effects of prostaglandin D2, but not its systemic vascular or airway effects, are mediated through thromboxane receptor activation. 1991 Circ. Res. pmid:1825033
Arzubiaga C et al. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. 1991 J. Allergy Clin. Immunol. pmid:1825102
Koshihara Y et al. Prostaglandin D2 stimulates calcification by human osteoblastic cells. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825424
Atsmon J et al. Modulation of the antiproliferative activity of 9-deoxy-delta 9,delta 12(E)-PGD2 by conjugation with intracellular glutathione. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825432
Hayaishi O Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2. 1991 FASEB J. pmid:1907936
Koizumi K et al. Induction of 31,000 protein by PGD2-treated vascular endothelial cells. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825433
Morrow JD et al. A stable isotope dilution mass spectrometric assay for the major urinary metabolite of PGD2. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825560
Howarth P et al. The comparative nasal effects of prostaglandin D2 in normal and rhinitic subjects. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825579
Gundel RH et al. The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late-phase bronchoconstriction and cellular infiltrates in primates. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825582
Watanabe K et al. The structure and function of prostaglandin F synthase. 1991 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:1825592
Murakami M et al. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. 1991 FEBS Lett. pmid:1756867
McMahon TJ et al. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed. 1991 J. Appl. Physiol. pmid:1837015
Conde B et al. Modulation of cell growth and differentiation induced by prostaglandin D2 in the glioma cell line C6. 1991 Jan-Feb Anticancer Res. pmid:1902073
Lundin-Schiller S and Mitchell MD Prostaglandin production by human chorion laeve cells in response to inflammatory mediators. 1991 Jul-Aug Placenta pmid:1946245
Naclerio RM Additional properties of cetirizine, a new H1 antagonist. 1991 May-Jun Allergy Proc pmid:1680095
van der Linden PW et al. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. 1992 J. Allergy Clin. Immunol. pmid:1629497
King KL et al. Metabolism of arachidonic acid by isolated rabbit ciliary epithelium. 1992 Exp. Eye Res. pmid:1426059
Thomas PS et al. Tobacco smoke releases performed mediators from canine mast cells and modulates prostaglandin production. 1992 Am. J. Physiol. pmid:1636731
Sasaguri T et al. Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. 1992 Exp. Cell Res. pmid:1572402
Sinzinger H et al. Isradipine improves platelet function in hypertensives. 1992 Eur. J. Clin. Pharmacol. pmid:1531796
Ito S et al. Type-1 and type-2 astrocytes are distinct targets for prostaglandins D2, E2, and F2 alpha. 1992 Glia pmid:1324890
Tsukagoshi H and Kurosawa M [Bronchial hyperresponsiveness to histamine induced by intravenous administration of prostaglandin D2 (PGD2) in guinea pigs]. 1992 Nippon Yakurigaku Zasshi pmid:1559641
Magnussen H et al. Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. 1992 J. Allergy Clin. Immunol. pmid:1535083
Gaetani P et al. Ex vivo release of eicosanoids after aneurysmal subarachnoid hemorrhage: a preliminary experience in humans. 1992 Acta Neurol. Scand. pmid:1414230
Katz HR et al. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. 1992 J. Immunol. pmid:1309842
Okayama Y et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. 1992 Clin. Exp. Allergy pmid:1375128
Okayama Y and Church MK Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. 1992 Int. Arch. Allergy Immunol. pmid:1375203
Smith JB et al. Cyclic AMP does not inhibit collagen-induced platelet signal transduction. 1992 Biochem. J. pmid:1375452
Ikai K et al. Induction of 72-kD heat shock protein and cytoskeleton damage by cytotoxic prostaglandin delta 12-PGJ2 in transformed human epidermal cells in culture. 1992 J. Invest. Dermatol. pmid:1375619
Yu SM et al. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. 1992 Biochem. Pharmacol. pmid:1310852
Lippton HL et al. Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed. 1992 Am. J. Physiol. pmid:1348400
Crea AE et al. Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma. 1992 Eur. Respir. J. pmid:1348480
Shin MH et al. The effect of azelastine on the early allergic response. 1992 Clin. Exp. Allergy pmid:1349259
Molderings G et al. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype. 1992 Br. J. Pharmacol. pmid:1330175
Mulkins MA et al. Mycophenolic acid inhibits the degranulation of rat peritoneal mast cells. 1992 Cell. Immunol. pmid:1349511
Conti P et al. Role of lipoxins A4 and B4 in the generation of arachidonic acid metabolites by rat mast cells and their effect on [3H]serotonin release. 1992 Immunol. Lett. pmid:1612634
Liu H et al. Regulation of the surface expression of the platelet-activating factor receptor in IC-21 peritoneal macrophages. Effects of lipopolysaccharide. 1992 J. Biol. Chem. pmid:1328211
González-Utor AL et al. Cytochemical localization of K(+)-dependent p-nitrophenyl phosphatase and adenylate cyclase by using one-step method in human washed platelets. 1992 Histochemistry pmid:1330994
Raible DG et al. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. 1992 J. Immunol. pmid:1588043
Amici C et al. Inhibition of Sendai virus replication by delta 12-prostaglandin J2: induction of heat shock protein synthesis and alteration of protein glycosylation. 1992 Antiviral Res. pmid:1332600
Seregi A et al. Functionally diverse purinergic P2Y-receptors mediate prostanoid synthesis in cultured rat astrocytes: the role of ATP-induced phosphatidyl-inositol breakdown. 1992 Eicosanoids pmid:1333251
Björnsson OG et al. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism. 1992 J. Lipid Res. pmid:1331281
Knani J et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. 1992 J. Allergy Clin. Immunol. pmid:1334102
Stellato C et al. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. 1992 Anesthesiology pmid:1280014
de Paulis A et al. Anti-inflammatory effect of FK-506 on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1281861
Tomita Y et al. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. 1992 Pigment Cell Res. pmid:1292020
Morii H and Watanabe Y A possible role of carbohydrate moieties in prostaglandin D2 and prostaglandin E2 receptor proteins from the porcine temporal cortex. 1992 Arch. Biochem. Biophys. pmid:1309289
Wang JP et al. Anti-inflammatory and analgesic effects of magnolol. 1992 Naunyn Schmiedebergs Arch. Pharmacol. pmid:1336574
Kuchinke W et al. A lung type prostaglandin F synthase is expressed in bovine liver: cDNA sequence and expression in E. coli. 1992 Biochem. Biophys. Res. Commun. pmid:1339268
Columbo M et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. 1992 J. Immunol. pmid:1378071
Goerg KJ et al. Inhibition of neuronally mediated secretion in rat colonic mucosa by prostaglandin D2. 1992 Gastroenterology pmid:1379954
Charlesworth EN et al. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. 1992 J. Pharmacol. Exp. Ther. pmid:1382132
Murakami M et al. Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. 1992 Eur. J. Biochem. pmid:1382985
Johnston SL et al. The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. 1992 Br J Clin Pharmacol pmid:1467134
Lin CH et al. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. 1992 Thromb. Res. pmid:1412184
Koizumi T et al. Inhibitory effect of an intracellular glutathione on delta 12-prostaglandin J2-induced protein syntheses in porcine aortic endothelial cells. 1992 Biochem. Pharmacol. pmid:1417983
Kaiser L et al. Dirofilaria immitis: do filarial cyclooxygenase products depress endothelium-dependent relaxation in the in vitro rat aorta? 1992 Exp. Parasitol. pmid:1516664
Braun M and Schrör K Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. 1992 Circ. Res. pmid:1385004
Goto H et al. Age-associated decreases in prostaglandin contents in human gastric mucosa. 1992 Biochem. Biophys. Res. Commun. pmid:1510674
Emery BE et al. The effect of IL-4 on human nasal mucosal responses. 1992 J. Allergy Clin. Immunol. pmid:1430703
Barrett KE Effect of histamine and other mast cell mediators on T84 epithelial cells. 1992 Ann. N. Y. Acad. Sci. pmid:1456653
Diener M et al. Characterization of the antisecretory action of prostaglandin D2 in the rat colon. 1992 Acta Physiol. Scand. pmid:1502910
Virgolini I et al. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor. 1992 J. Biol. Chem. pmid:1377673
Watanabe-Kohno S et al. MCI-826 is a potent and selective antagonist of peptide leukotrienes (p-LTs) and has characteristics distinctive from those of FPL 55712. 1992 Jpn. J. Pharmacol. pmid:1460800
Baumgarten CR et al. Bradykinin and other inflammatory mediators in BAL-fluid from patients with active pulmonary inflammation. 1992 Agents Actions Suppl. pmid:1462881
Ellis JL and Undem BJ Antigen-induced enhancement of noncholinergic contractile responses to vagus nerve and electrical field stimulation in guinea pig isolated trachea. 1992 J. Pharmacol. Exp. Ther. pmid:1323657
Tamaoki J et al. Prostaglandin D2 increases Cl secretion across canine tracheal epithelium through cyclo-oxygenase stimulation and cAMP production. 1992 Acta Physiol. Scand. pmid:1323920
Froldi M et al. Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement. 1992 J. Neuroimmunol. pmid:1315794
Fukushima M Biological activities and mechanisms of action of PGJ2 and related compounds: an update. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1438462
Shimakura S and Boland CR Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. 1992 Cancer Res. pmid:1551103
Ninomiya H et al. Endothelin-1 induces stimulation of prostaglandin synthesis in cells obtained from canine airways by bronchoalveolar lavage. 1992 Prostaglandins pmid:1584994
Lee DY et al. Prostaglandin profile and synthetic capacity of the colon: comparison of tissue sources and subcellular fractions. 1992 Prostaglandins pmid:1542741
Picado C et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. 1992 Am. Rev. Respir. Dis. pmid:1309968
Kawada N et al. Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells. 1992 Gastroenterology pmid:1499903
Koizumi T et al. Induction of heme oxygenase by delta 12-prostaglandin J2 in porcine aortic endothelial cells. 1992 Prostaglandins pmid:1542739
Eguchi N et al. Permeability of brain structures and other peripheral tissues to prostaglandins D2, E2 and F2 alpha in rats. 1992 J. Pharmacol. Exp. Ther. pmid:1527717
Rangachari PK Concerning prostaglandin D2: forgotten, promiscuous, capricious. 1992 Ann. N. Y. Acad. Sci. pmid:1456655
Krueger JM et al. Prostaglandins E2 and D2 have little effect on rabbit sleep. 1992 Physiol. Behav. pmid:1523224
D'Onofrio C et al. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells. 1992 Int. J. Cancer pmid:1592539
Wang D et al. Terbutaline acts at multiple sites to inhibit bronchoconstriction induced by dry air in canine peripheral airways. 1992 Am. Rev. Respir. Dis. pmid:1595994
Hogaboam CM et al. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds. 1992 Br. J. Pharmacol. pmid:1596692